Department of Epidemiology, Prevention of Cardiovascular Disease and Health Promotion, Institute of Cardiology, Warsaw, Poland.
Kardiol Pol. 2012;70(9):897-902.
Although there is a considerable epidemiologic evidence for a relation between homocysteine (Hcy) level and cardiovascular disease (CVD). The role of Hcy as a causal risk factor remains controversial.
To determine associations between Hcy level and all-cause and cardiovascular mortality in general population of Poland.
Within the frame of the National Multicenter Health Survey (WOBASZ), a representative sample of whole Polish population aged 20-74 was screened in years 2003-2005 and prospectively followed up until 2009. Baseline determinations, among other classical risk factors, included Hcy level in 7165 responders, performed by an immunoenzymatic method using IMMULITE 1 analyser and DPC reagents. Survival rates were followed up until 2009 and average follow up time was 5.4 years.
During the 38,818.9 person-years of follow-up there were 270 deaths including 108 due to CVD, 37 due to coronary heart disease and 21 due to stroke. The relative risk of all-cause and CVD mortality was significantly higher in the highest (> 10.51 μmol/L) compared to the lowest (< 8.20 μmol/L) Hcy tercile in crude and multivariable proportional hazards models adjusted for sex, age, smoking status, hypertension, body mass index, total cholesterol, glucose and high sensitivity-C-reactive protein. Hazards ratios (95% confidence intervals) were as follows: all-cause mortality HR (95% CI): crude = 4.528 (2.947-6.154), multivariable-adjusted = 1.766 (1.197-2.605), CVD mortality crude = 4.322 (2.426-7.700), multivariable- -adjusted = 1.937 (1.051-3.569).
In Polish adult population Hcy concentration is independently associated with all-cause and CVD mortality.
尽管有相当多的流行病学证据表明同型半胱氨酸(Hcy)水平与心血管疾病(CVD)之间存在关联,但 Hcy 作为因果风险因素的作用仍存在争议。
确定波兰普通人群中 Hcy 水平与全因和心血管死亡率之间的关联。
在全国多中心健康调查(WOBASZ)框架内,于 2003-2005 年对 20-74 岁的波兰全体人口进行了代表性抽样筛查,并前瞻性随访至 2009 年。在 7165 名应答者中,通过使用 IMMULITE 1 分析仪和 DPC 试剂的免疫酶法测定了其他经典危险因素,包括 Hcy 水平。在 2009 年之前随访生存率,平均随访时间为 5.4 年。
在 38818.9 人年的随访期间,有 270 人死亡,其中 108 人死于 CVD,37 人死于冠心病,21 人死于中风。在未经调整和多变量比例风险模型中,与最低(<8.20 μmol/L)相比,最高(>10.51 μmol/L)Hcy 三分位数的全因和 CVD 死亡率的相对风险明显更高,模型调整了性别、年龄、吸烟状况、高血压、体重指数、总胆固醇、血糖和高敏 C 反应蛋白。风险比(95%置信区间)如下:全因死亡率 HR(95%CI):未经调整=4.528(2.947-6.154),多变量调整=1.766(1.197-2.605),CVD 死亡率未经调整=4.322(2.426-7.700),多变量调整=1.937(1.051-3.569)。
在波兰成年人群中,Hcy 浓度与全因和 CVD 死亡率独立相关。